Cambridge Investment Research Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.37M | Sell |
|
|||||
|
2025
Q1 | $4.83M | Sell |
|
|||||
|
2024
Q4 | $5.89M | Sell |
|
|||||
|
2024
Q3 | $7.03M | Buy |
|
|||||
|
2024
Q2 | $6.39M | Sell |
|
|||||
|
2024
Q1 | $7.23M | Buy |
|
|||||
|
2023
Q4 | $5.89M | Sell |
|
|||||
|
2023
Q3 | $5.63M | Sell |
|
|||||
|
2023
Q2 | $9.25M | Buy |
|
|||||
|
2023
Q1 | $5.71M | Buy |
|
|||||
|
2022
Q4 | $5.65M | Sell |
|
|||||
|
2022
Q3 | $5.47M | Sell |
|
|||||
|
2022
Q2 | $14.4M | Buy |
|
|||||
|
2022
Q1 | $4.88M | Sell |
|
|||||
|
2021
Q4 | $7.78M | Buy |
|
|||||
|
2021
Q3 | $7.84M | Buy |
|
|||||
|
2021
Q2 | $8.43M | Sell |
|
|||||
|
2021
Q1 | $11M | Buy |
|
|||||
|
2020
Q4 | $10.6M | Buy |
|
|||||
|
2020
Q3 | $6.57M | Buy |
|
|||||
|
2020
Q2 | $6.19M | Buy |
|
|||||
|
2020
Q1 | $2.87M | Sell |
|
|||||
|
2019
Q4 | $4.58M | Buy |
|
|||||
|
2019
Q3 | $3.09M | Sell |
|
|||||
|
2019
Q2 | $3.63M | Buy |
|
|||||
|
2019
Q1 | $3.71M | Buy |
|
|||||
|
2018
Q4 | $2.79M | Sell |
|
|||||
|
2018
Q3 | $6.7M | Sell |
|
|||||
|
2018
Q2 | $7.98M | Buy |
|
|||||
|
2018
Q1 | $3.46M | Buy |
|
|||||
|
2017
Q4 | $2.18M | Sell |
|
|||||
|
2017
Q3 | $2.94M | Buy |
|
|||||
|
2017
Q2 | $2.02M | Buy |
|
|||||
|
2017
Q1 | $1.59M | Buy |
|
|||||
|
2016
Q4 | $1.32M | Buy |
|
|||||
|
2016
Q3 | $877K | Sell |
|
|||||
|
2016
Q2 | $727K | Buy |
|
|||||
|
2016
Q1 | $672K | Sell |
|
|||||
|
2015
Q4 | $951K | Buy |
|
|||||
|
2015
Q3 | $780K | Sell |
|
|||||
|
2015
Q2 | $2.35M | Sell |
|
|||||
|
2015
Q1 | $2.22M | Buy |
|
|||||
|
2014
Q4 | $1.51M | Buy |
|
|||||
|
2014
Q3 | $1.06M | Sell |
|
|||||
|
2014
Q2 | $1.07M | Sell |
|
|||||
|
2014
Q1 | $5.49M | Buy |
|
|||||
|
2013
Q4 | $1.97M | Buy |
|
|||||
|
2013
Q3 | $1.51M | Buy |
|
|||||
|
2013
Q2 | $986K | Buy |
|